(Q37738414)

22 August 2017

1 reference

title

Treatment of Burkitt lymphoma in children and adults: Lessons from Africa (English)

1 reference

22 August 2017

0 references

Ian T Magrath

1

1 reference

22 August 2017

publication date

1 December 2006

1 reference

Current hematologic malignancy reports

22 August 2017

published in

1 reference

22 August 2017

volume

1

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

230-240

1 reference

Cerebrospinal irradiation of Burkitt's lymphoma. Failure in preventing central nervous system relapse

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11899-006-0004-9

Long-term remissions following one and two-dose chemotherapy for African lymphoma

21 January 2018

1 reference

12 December 2020

Survival of Burkitt's lymphoma patients in Mulago Hospital, Uganda

1 reference

12 December 2020

Follicular lymphoma with a burkitt translocation--predictor of an aggressive clinical course: a case report and review of the literature

1 reference

12 December 2020

Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children

1 reference

12 December 2020

Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience

1 reference

12 December 2020

[Treatment strategies in malignant non-Hodgkin lymphomas in childhood]

1 reference

12 December 2020

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial

1 reference

12 December 2020

Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group

1 reference

12 December 2020

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

1 reference

12 December 2020

Prognostic factors in Burkitt's lymphoma importance of total tumor burden

1 reference

12 December 2020

An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults

1 reference

12 December 2020

Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse

1 reference

12 December 2020

Improved outcome in adult B-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Rituximab-CHOP or two-weekly CHOP + G-CSF in aggressive lymphoma of the elderly?

1 reference

12 December 2020

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

1 reference

12 December 2020

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.

1 reference

12 December 2020

High-dose methotrexate and continuous infusion Ara-C in children's non-Hodgkin's lymphoma: phase II studies and their use in further protocols

1 reference

12 December 2020

Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas

1 reference

12 December 2020

Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol

1 reference

12 December 2020

Intensive chemotherapy in patients with generalized Burkitt's lymphoma

1 reference

12 December 2020

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte

1 reference

12 December 2020

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

1 reference

12 December 2020

Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols

1 reference

12 December 2020

HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign?

1 reference

12 December 2020

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma

1 reference

12 December 2020

Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.

1 reference

12 December 2020

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas.

1 reference

12 December 2020

Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group

1 reference

12 December 2020

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

1 reference

12 December 2020

Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients

1 reference

12 December 2020

Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas

1 reference

12 December 2020

Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity

1 reference

12 December 2020

Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol

1 reference

12 December 2020

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma

1 reference

12 December 2020

Adult Burkitt leukemia and lymphoma

1 reference

12 December 2020

Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas

1 reference

12 December 2020

Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient

1 reference

12 December 2020

Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen

1 reference

12 December 2020

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

12 December 2020

Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

1 reference

12 December 2020

African Burkitt's lymphoma. History, biology, clinical features, and treatment

1 reference

12 December 2020

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

1 reference

12 December 2020

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

1 reference

12 December 2020

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

1 reference

12 December 2020

Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia

1 reference

12 December 2020

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

12 December 2020

Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy

1 reference

12 December 2020

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

12 December 2020

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

1 reference

12 December 2020

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

Chemotherapy of Burkitt's Tumor at the University of Ibadan, Nigeria

1 reference

12 December 2020

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma

1 reference

12 December 2020

Intrathecal Chemotherapy in Burkitt's Lymphoma

1 reference

12 December 2020

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs

1 reference

12 December 2020

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival

1 reference

12 December 2020

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine

1 reference

12 December 2020

Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology

1 reference

12 December 2020

High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma

1 reference

12 December 2020

Long‐term experience with burkitt's lymphoma in uganda

1 reference

12 December 2020

High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults

1 reference

12 December 2020

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

Ifosfamide in the treatment of high-grade recurrent non-hodgkin's lymphomas

1 reference

12 December 2020

Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantat

1 reference

12 December 2020

Molecular diagnosis of Burkitt's lymphoma

1 reference

12 December 2020

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.

1 reference

12 December 2020

Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin's lymphomas): parolonged unmaintained remissions

1 reference

12 December 2020

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

12 December 2020

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)

1 reference

12 December 2020

Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.

1 reference

12 December 2020

Treatment of Burkitt's tumor with cyclophosphamide

1 reference

12 December 2020

Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival

1 reference

12 December 2020

A sarcoma involving the jaws in African children

1 reference

12 December 2020

Glucose-6-Phosphate Dehydrogenase (G-6-PD) Markers in Burkitt Lymphoma and Other Malignancies

1 reference

12 December 2020

The BFM-protocol for HIV-negative Burkitt's lymphomas and L3 ALL in adult patients: a high chance for cure

1 reference

12 December 2020

10.1007/S11899-006-0004-9

Identifiers

DOI

1 reference

release_vjb6ii75ljeonlhcbwwedcrsvy

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vjb6ii75ljeonlhcbwwedcrsvy

24 November 2022

mapped directly with Wikidata item

1 reference